Last reviewed · How we verify
Sanfu herbal patch and moxibustion
Sanfu herbal patch and moxibustion is a Small molecule drug developed by Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust. It is currently in Phase 2 development.
At a glance
| Generic name | Sanfu herbal patch and moxibustion |
|---|---|
| Sponsor | Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sanfu herbal patch and moxibustion CI brief — competitive landscape report
- Sanfu herbal patch and moxibustion updates RSS · CI watch RSS
- Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust portfolio CI
Frequently asked questions about Sanfu herbal patch and moxibustion
What is Sanfu herbal patch and moxibustion?
Sanfu herbal patch and moxibustion is a Small molecule drug developed by Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust.
Who makes Sanfu herbal patch and moxibustion?
Sanfu herbal patch and moxibustion is developed by Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust (see full Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust pipeline at /company/hubei-provincial-collaborative-innovation-center-of-preventive-treatment-by-acup).
What development phase is Sanfu herbal patch and moxibustion in?
Sanfu herbal patch and moxibustion is in Phase 2.